Attendee search 

Under the “China-U.S. Strategic and Economic Dialogue (S&ED)” agreement, the U.S.- China Health Summit was inaugurated at Harvard University in September 2011 and has been alternately hosted by China and the United States. Over the past five years, policymakers, academic experts, and business leaders who have a keen interest in the rapidly transforming global health sector have all benefited tremendously from these direct dialogues and discussions. The Summit has been endorsed by the U.S. Department of Human and Health Services, the China Commission of Health and Family Planning, Harvard T.H Chan School of Public Health, Tsinghua University School of Public Policy & Management, and Peking Union Medical College.

In addition to the annual Summit, the UCHS also hold innovation centered events including Innovation competition, workshops and meetups, to assist health innovators in developing solutions for unmet medical needs in the global health ecosystem.

As one of the top universities in Asia-Pacific, The Chinese University of Hong Kong (CUHK) is committed to knowledge transfer and seeks to foster partnerships to commercialise our university’s technologies in the best way to benefit both industry and society. In this regard, CUHK is continuously looking for potential partners/licensees in our below areas of biomedical technologies:

(1)   Therapeutics: Digestive Cancer / Diabetes / Liver Cancer / Neurological Disorders / Orthopaedic and Traumatological Disorders / Pluripotent Stem Cells (see https://goo.gl/Ozm5Gz)

(2)   Diagnostics: Cardiovascular Disorders / Digestive Cancers / Diabetes & its Comorbidities / Gynecology and Obstetrics / Orthopaedic & Traumatological Disorders / Wearables (see https://goo.gl/gcbdLF)

(3) Robotics: Surgical Robots / Endoscopes for Minimally Invasive Surgery and Diagnostic Purposes (see https://goo.gl/TrQSrz)